Program death ligand‐1 immunocytochemistry in lung cancer cytological samples: a systematic review
S Satturwar, I Girolami, E Munari… - Diagnostic …, 2022 - Wiley Online Library
In this era of personalized medicine, targeted immunotherapies like immune checkpoint
inhibitors (ICI) blocking the programmed death‐1 (PD‐1)/program death ligand‐1 (PD‐L1) …
inhibitors (ICI) blocking the programmed death‐1 (PD‐1)/program death ligand‐1 (PD‐L1) …
PD‐L1 immunohistochemical testing: a review with reference to cytology specimens
LJ Layfield, T Zhang, M Esebua - Diagnostic Cytopathology, 2023 - Wiley Online Library
Background Immunotherapy based on disruption of the PD‐1/PD‐L1 axis is standard of care
for many high stage malignancies including melanomas, non‐small cell carcinomas of the …
for many high stage malignancies including melanomas, non‐small cell carcinomas of the …
Pragmatic expectancy on microbiota and non-small cell lung cancer: a narrative review
Simple Summary Growing evidence suggests that the microbiota—or better, the changes in
microbiota composition and characteristics—plays a role in lung cancer onset and is …
microbiota composition and characteristics—plays a role in lung cancer onset and is …
CT Scan-Guided Fine Needle Aspiration Cytology for Lung Cancer Diagnosis through the COVID-19 Pandemic: What We Have Learned
GM Stella, V Chino, P Putignano, F Bertuccio… - Tomography, 2023 - mdpi.com
Background and rationale. Novel coronavirus-related disease (COVID-19) has profoundly
influenced hospital organization and structures worldwide. In Italy, the Lombardy Region …
influenced hospital organization and structures worldwide. In Italy, the Lombardy Region …